Celldex Therapeutics, Inc. (CLDX) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

ladies and gentlemen this is the operator today's conference call will begin in two minutes until that time your lines will again be placed on hold thank you for your patience again ladies and gentlemen this is the operator today's conference call will begin in two minutes until that time your lines will again be placed on hold thank you for your patience Thank you. Thank you. Ladies and gentlemen, thank you for standing by and welcome to the Celltex Therapeutics year-end 2021 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1 on your telephone. please be advised that today's conference call is being recorded. If you require any further assistance, please press star zero. I would now like to hand the conference over to your speaker today, Sarah Cavanaugh. Thank you. Please go ahead. Good afternoon, and welcome to the Celldex Therapeutics fourth quarter and full year 2021 financial results and corporate update conference call. Just to remind everyone, certain matters discussed in today's conference call and or answers that may be given to questions asked are forward-looking statements that are subject to risks and uncertainties relating to future events and or the financial future performance of the company. Actual results could differ materially from those anticipated in these forward-looking statements. The risk factors that may affect results are detailed in Celldex's most recent filings with the U.S. Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2021, which can be found on our website, celldex.com, or on sec.gov. A question and answer...